Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(}function setPanelState(o){dom.root.classList[o?"add":"remove"](,dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //


Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Today's Trading

Day Low 271.39
Day High 274.75
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.



A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.


What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.


A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

Life Science Cares and Biogen Foundation Help Launch Food For Free's Just Eats Program
- Globe Newswire - Wed Feb 24, 6:30AM CST
Globe Newswire - CMTX
Wed Feb 24, 6:30AM CST
- $170,000 grants will fill critical gap for 3,000 food insecure families in Greater Boston via Food For Free's new grocery box program
Biogen Announces the Expiration Date Results of Its Cash Tender Offer
- GlobeNewswire - Thu Feb 11, 7:03AM CST
GlobeNewswire - CMTX
Thu Feb 11, 7:03AM CST
Biogen Inc. ("Biogen") (Nasdaq: BIIB) today announced the expiration date results of its previously announced offer to purchase for cash (the "Cash Offer") its outstanding 5.200% Senior Notes due 2045 (the "Notes"), totaling $1.75 billion in aggregate principal amount, on the terms and subject to the conditions set forth in the Offer to Purchase dated February 4, 2021 (the "Offer to Purchase") and the accompanying certification of eligibility to participate in the Cash Offer, the instructions for such certification and the notice of guaranteed delivery (collectively, the "Cash Offer Documents").
Biogen Announces the Expiration Date Results of Its Private Exchange Offer
- Globe Newswire - Thu Feb 11, 7:00AM CST
Globe Newswire - CMTX
Thu Feb 11, 7:00AM CST
CAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. ("Biogen") (Nasdaq: BIIB) today announced the expiration date results of its previously announced private offer to exchange (the "Exchange Offer") any and all of its outstanding 5.200% Senior Notes due 2045 (the "Old Notes"), totaling $1.75 billion in aggregate principal amount, for a new series of 3.250% senior notes due 2051 to be issued by Biogen (the "New Notes") and cash on the terms and subject to conditions set forth in the Offering Memorandum dated February 4, 2021 (the "Offering Memorandum") and the accompanying eligibility letter (the "Eligibility Letter"), Canadian beneficial holder form and notice of guaranteed delivery (collectively, the "Exchange Offer Documents").
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 260.97 +4.70% increase
on 02/04/21
Period Open:278.46
Price movement based on the high, low and last over the given period.
288.08 -5.15% decrease
on 02/22/21
-5.23 (-1.88%) decrease
since 02/01/21
3-Month 238.40 +14.61% increase
on 01/04/21
Period Open:243.16
Price movement based on the high, low and last over the given period.
296.38 -7.81% decrease
on 01/29/21
+30.07 (+12.37%) increase
since 12/01/20
52-Week 223.25 +22.39% increase
on 11/09/20
Period Open:308.39
Price movement based on the high, low and last over the given period.
363.92 -24.92% decrease
on 11/04/20
-35.16 (-11.40%) decrease
since 02/28/20

More stories below advertisement

' ].join(''); bioEp.init({ html: html, width: 608, cookieExp: 0, delay: 0, onPopup: function () { exitPopupPushAnalytics('popupDisplay') } }); } function popupClickSubscribe(tag) { exitPopupPushAnalytics('clickSubscribe-' + tag); var url = '' + tag; window.location.href = url; } function exitPopupPushAnalytics(action) { window.analyticsLayer.push({ "event": "clickEvent", "clickEvent": { "testId": "cem1697", "feature": "promotions", "action": action, "type": "test", "label": action, "variantName": "experience", "segmentName": "popup" } }) }

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies